ETF Holdings Breakdown of MGTX

News associated with MGTX

Geode Capital Management LLC Raises Position in MeiraGTx Holdings plc (NASDAQ:MGTX)

Geode Capital Management LLC lifted its stake in MeiraGTx Holdings plc (NASDAQ:MGTX – Free Report) by 16.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 570,646 shares of the company’s stock after acquiring an additional 80,407 shares during the quarter. Geode Capital Management LLC’s holdings in MeiraGTx were worth $3,475,000 as of […] - 2025-04-28 08:05:07

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by CreativeOne Wealth LLC

CreativeOne Wealth LLC lowered its position in MeiraGTx Holdings plc (NASDAQ:MGTX – Free Report) by 24.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,999 shares of the company’s stock after selling 14,575 shares during the period. CreativeOne Wealth LLC’s holdings in MeiraGTx were […] - 2025-04-21 07:58:51

Trexquant Investment LP Makes New $240,000 Investment in MeiraGTx Holdings plc (NASDAQ:MGTX)

Trexquant Investment LP bought a new stake in MeiraGTx Holdings plc (NASDAQ:MGTX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 39,348 shares of the company’s stock, valued at approximately $240,000. Trexquant Investment LP owned approximately 0.05% of MeiraGTx […] - 2025-04-14 08:03:10

MeiraGTx (NASDAQ:MGTX) vs. CRISPR Therapeutics (NASDAQ:CRSP) Head-To-Head Review

MeiraGTx (NASDAQ:MGTX – Get Free Report) and CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Volatility & Risk MeiraGTx has a beta of 1.23, […] - 2025-03-24 06:09:08

Royal Bank of Canada Issues Positive Forecast for MeiraGTx (NASDAQ:MGTX) Stock Price

MeiraGTx (NASDAQ:MGTX – Get Free Report) had its price objective raised by Royal Bank of Canada from $11.00 to $13.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of 73.33% from the stock’s previous […] - 2025-03-19 05:58:56

Los Angeles Capital Management LLC Has $282,000 Stock Position in MeiraGTx Holdings plc (NASDAQ:MGTX)

Los Angeles Capital Management LLC lowered its position in MeiraGTx Holdings plc (NASDAQ:MGTX – Free Report) by 51.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,370 shares of the company’s stock after selling 48,990 shares during the quarter. Los […] - 2025-03-05 10:41:05

DAVENPORT & Co LLC Increases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX)

DAVENPORT & Co LLC lifted its stake in shares of MeiraGTx Holdings plc (NASDAQ:MGTX – Free Report) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 77,200 shares of the company’s stock after acquiring an additional 5,000 shares during the […] - 2025-02-08 08:38:52

MGTX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-09	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	37,034	USD 200,724 -0.9%
2025-05-09	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	37,034	USD 200,724 -0.9%
Total =		74,068	USD 401,448

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer